XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-In Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total Green Plains Stockholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-In Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accum. Other Comp. Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Total Green Plains Stockholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Non-Controlling Interests [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accum. Other Comp. Income (Loss) [Member]
Treasury Stock [Member]
Total Green Plains Stockholders' Equity [Member]
Non-Controlling Interests [Member]
Total
Beginning balance at Dec. 31, 2018                         $ 47 $ 696,222 $ 324,728 $ (16,016) $ (58,162) $ 946,819 $ 116,170 $ 1,062,989
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018                         46,638,000       5,536,000      
Net income (loss)                             (166,860)     (166,860) 18,860 (148,000)
Other comprehensive loss before reclassification                               55,973        
Amounts reclassified from accumulated other comprehensive loss                               (38,795)        
Other comprehensive loss, net of tax                                       4,952
Other comprehensive income, net of tax                               17,178   17,178   17,178
Share of equity method investees other comprehensive loss arising during the period, net of tax                               (12,226)   (12,226)   (12,226)
Proceeds from disgorgement of shareholders short-swing profits, net                           5,054       5,054   5,054
Issuance of 4.00% converatible notes due 2024, net of tax                           24,928       24,928   24,928
Settlements of 3.25% convertible notes due 2019, net of tax                           (271)       (271)   (271)
Repurchase of common stock                                 $ (61,646) (61,646)   (61,646)
Repurchase of common stock, Shares                                 5,396,000      
Stock-based compensation                           7,052       7,052   7,371
Stock-based compensation                                     319  
Stock-based compensation, Shares                         207,000              
Stock options exercised                           1,595       1,595   1,595
Stock options exercised, Shares                         119,000              
Ending balance at Dec. 31, 2019                         $ 47 734,580 148,150 (11,064) $ (119,808) 751,905 113,381 865,286
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2019                         46,964,000       10,932,000      
Net income (loss)                             (108,775)     (108,775) 19,121 (89,654)
Cash dividends and distributions declared                                       (9,675)
Distributions declared                                     (9,675)  
Other comprehensive loss before reclassification                               (768)        
Amounts reclassified from accumulated other comprehensive loss                               (2,566)        
Other comprehensive loss, net of tax                                       8,892
Other comprehensive income, net of tax                               (3,334)   (3,334)   (3,334)
Share of equity method investees other comprehensive loss arising during the period, net of tax                               12,226   12,226   12,226
Acquisition of subsidiary                                     6,667 6,667
Repurchase of common stock                                 $ (11,479) (11,479)   (11,479)
Repurchase of common stock, Shares                                 881,000      
Stock-based compensation                           6,309       6,309   6,627
Stock-based compensation                                     318  
Stock-based compensation, Shares                         507,000              
Ending balance at Dec. 31, 2020 $ (49,496) $ 11,418 $ (38,078) $ (38,078) $ 47 $ 691,393 $ 50,793 $ (2,172) $ (131,287) $ 608,774 $ 129,812 $ 738,586 $ 47 740,889 39,375 (2,172) $ (131,287) 646,852 129,812 $ 776,664
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2020         47,471,000       11,813,000       47,471,000       11,813,000     35,657,344
Net income (loss)                             (65,992)     (65,992) 21,846 $ (44,146)
Cash dividends and distributions declared                                       (9,251)
Distributions declared                                     (9,251)  
Other comprehensive loss before reclassification                               (24,230)        
Amounts reclassified from accumulated other comprehensive loss                               14,092        
Other comprehensive loss, net of tax                                       (10,138)
Other comprehensive income, net of tax                               (10,138)   (10,138)   (10,138)
Repurchase of common stock                                       $ (11,500)
Repurchase of common stock, Shares                                       880,979
Exchange of 4.00% convertible notes due 2024                           17,683     $ 39,661 57,344   $ 57,344
Exchange of 4.00% convertible notes due 2024, Shares                                 (3,569,000)      
Issuance of common stock for cash at per share, net of fees                         $ 15 355,963       355,978   355,978
Stock Issued During Period, Shares, New Issues                         14,214,000              
Investment in subsidiary                                     12,264 12,264
Issuance of warrants                           3,431       3,431 (3,431)  
Stock-based compensation                           1,103       1,103   1,382
Stock-based compensation                                     279  
Stock-based compensation, Shares                         155,000              
Ending balance at Dec. 31, 2021                         $ 62 $ 1,069,573 $ (15,199) $ (12,310) $ (91,626) $ 950,500 $ 151,519 $ 1,102,019
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2021                         61,840,000       8,244,000     53,595,978